Meetings: National Institute on Drug Abuse,
[Federal Register: January 9, 2008 (Volume 73, Number 6)]
[Notices]
[Page 1632]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09ja08-52]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Synthesis and Distribution of Drugs of Abuse and Related Compounds.
Date: January 23, 2008.
Time: 9 a.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892- 8401, (301) 435-1439, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Drug Abuse Screening, Assessment, Patient-Treatment Matching Technologies for Use in Primary Care.
Date: January 24, 2008.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Kristen V. Huntley, PhD., Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, 301-435-1433, huntleyk@mail.nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Development of Nanoscience-based Probes, Delivery Systems, and Therapies for Substance Use Disorders.
Date: January 30, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892- 8401, (301) 435-1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Dated: January 3, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-44 Filed 1-8-08; 8:45 am]
BILLING CODE 4140-01-M
